Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Oct;77(10):1583-1585.
doi: 10.1007/s00228-021-03128-7. Epub 2021 May 12.

Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis

Massimo Tempestilli  1 , Giulia Valeria Stazi  1 , Gaetano Maffongelli  1 , Maria Cristina Marini  1 , Tommaso Ascoli Bartoli  1 , Giuseppe Ippolito  1 , Emanuele Nicastri  1 , Luisa Marchioni  1 , Chiara Agrati  2
Affiliations
Case Reports

Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis

Massimo Tempestilli et al. Eur J Clin Pharmacol. 2021 Oct.

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Plasma concentrations of main remdesivir metabolite (GS-441524) 24 h after intravenous remdesivir therapy in a critically ill patient undergoing CVVHD cycles. Remdesivir IV infusions (arrows) were performed after each single CVVHD session (grey boxes). Each box shows the GS-441524 decrease. Dashed line represents the mean C24 of GS-441524 found in healthy adult subjects [3]
See this image and copyright information in PMC

References

    1. Wise J. Covid-19: Remdesivir is recommended for authorisation by European medicines agency. BMJ. 2020;369:m2610. doi: 10.1136/bmj.m2610. - DOI - PubMed
    1. Veklury (remdesivir): EU summary of product characteristics. 2020. https://www.ema.europa.eu/en/documents/other/veklury-product-information...
    1. Veklury (remdesivir) EUA Fact Sheet for Healthcare Providers, updated 10/22/20. https://www.fda.gov/media/137566/download
    1. Adamsick ML, Gandhi RG, Bidell MR, Elshaboury RH, Bhattacharyya RP, Kim AY, Nigwekar S, Rhee EP, Sise ME. Remdesivir in patients with acute or chronic kidney disease and COVID-19. J Am Soc Nephrol. 2020;31:1384–1386. doi: 10.1681/ASN.2020050589. - DOI - PMC - PubMed
    1. Avataneo V, de Nicolò A, Cusato J, Antonucci M, Manca A, Palermiti A, Waitt C, Walimbwa S, Lamorde M, di Perri G, D'Avolio A. Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. J Antimicrob Chemother. 2020;75:1772–1777. doi: 10.1093/jac/dkaa152. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources